Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

Fig. 2

Mean observed change from baseline in PASP and FVC in nintedanib prospective study. a The mean observed change from baseline in pulmonary artery systolic pressure (PASP) after starting nintedanib treatment. The value of the mean changes in PASP gradually increased and PASP was significantly higher at 48 weeks after nintedanib treatment than at baseline (P = 0.001). b The mean value of changes in forced vital capacity (FVC) gradually decreased and were significantly lower at 48 weeks after nintedanib treatment than at baseline (P = 0.021). Changes in mean PASP and FVC from baseline to 48 weeks after treatment were assessed using a paired t-test. Two-sided P-values  0.05 were considered significant

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us